[An Intestinal Metabolite Exacerbates Stress-induced Diarrhea].

Abstract

Irritable bowel syndrome (IBS) constitutes a chronic functional gastrointestinal disorder characterized by abdominal pain and irregular bowel habits. Diagnosis typically hinges upon symptomatology, following the exclusion of organic pathologies such as intestinal inflammation and malignancies. IBS manifests with diverse symptoms attributable to aberrant intestinal function, including diarrhea, constipation, and bloating, stratified into four types based on the predominance of diarrhea versus constipation. Radical treatment for IBS remains elusive due to its unknown pathology and etiology, thereby necessitating symptom-focused therapeutic approaches. Certain conditions such as psychiatric disorders, intestinal inflammation, food sensitivities, and Small Intestinal Bacterial Overgrowth (SIBO) exhibit overlaps with or correlations to symptoms of IBS, suggesting that treatment targeting these conditions may ameliorate symptoms of IBS. Emotional stress emerges as a principal risk factor for IBS, precipitating alterations in stress hormone levels and intestinal motility, thereby instigating a spectrum of symptoms associated with the disorder. Additional risk factors for IBS exhibit considerable variability among individuals, encompassing dietary factors that stimulate or influence intestinal function, gluten, the presence of fermentable carbohydrates (fermentable oligosaccharides disaccharides monosaccharides and polyols: FODMAPs), and aspects of the intestinal microbiota and its metabolites. Notably, individuals with IBS demonstrate distinctive alterations in gut microbiota composition compared to healthy controls, indicative of dysbiosis. Furthermore, changes in metabolites such as short-chain fatty acids (SCFAs) in some IBS patients are recognized. In summary, while the precise etiology and underlying pathology of IBS remain elusive, management typically necessitates a multifaceted approach involving lifestyle modifications, targeted symptom therapies, occasional psychological support, and adjunctive measures to regulate the intestinal environment.